Fundz

RedHill Biopharma secures $6 million via a private placement, aiming for up to $19.4 million. The offering is led by H.C. Wainwright & Co.

PUBLIC · RDHLJun 18, 2026

Amount Raised

$6 Million

Round Type

Post-IPO Equity

RaleighManufacturingBiotechnologyHealthcareSoftwareHealth CareScience And Engineering

Investors

H.C. Wainwright & Co.

Description

RedHill Biopharma Ltd. announced a definitive agreement for a private placement, expecting $6 million upfront. The company could potentially raise an additional $13.4 million through the exercise of warrants. The offering will close on June 22, 2026, pending customary conditions

Quick answer

RedHill Biopharma Ltd raised $6 Million in a Post-IPO Equity round, dated June 18, 2026. Investors: H.C. Wainwright & Co. RedHill Biopharma Ltd is based in Raleigh, North Carolina, United States.

How much did RedHill Biopharma Ltd raise?
RedHill Biopharma Ltd raised $6 Million in a Post-IPO Equity round on June 18, 2026.
Who invested in RedHill Biopharma Ltd?
H.C. Wainwright & Co. is named as investors in this round.
What does RedHill Biopharma Ltd do?
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. The company..
Where is RedHill Biopharma Ltd based and how big is it?
RedHill Biopharma Ltd is based in Raleigh, North Carolina, United States.
Who are the decision-makers at RedHill Biopharma Ltd?
Fundz holds 1 contact at RedHill Biopharma Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as RedHill Biopharma Ltd that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $2.9M on July 3, 2026.
  • Advanced NanoTherapies raised $31M (Series B) on June 2, 2026.
  • Beyond Air raised $30M (Post-IPO Equity) on July 30, 2026.
  • Elle MD Biotechnologies raised $1.1M (Seed) on July 29, 2026.
  • Xeltis raised $23M on July 28, 2026.
  • KMM Group raised an undisclosed amount on July 27, 2026.

Who to call at RedHill Biopharma Ltd, and when

A new round usually means RedHill Biopharma Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RedHill Biopharma Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RedHill Biopharma Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RedHill Biopharma Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RedHill Biopharma Ltd

Location

Raleigh, North Carolina, United States

About

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. The company markets Talicia®, an FDA-approved treatment for H. pylori infection, and is advancing late-stage programs including opaganib, a first-in-class SPHK2 inhibitor; RHB-204 for Crohn’s disease and nontuberculous mycobacteria (NTM) infections; RHB-107 (upamostat) for COVID-19 and inflammatory diseases; and RHB-102 for nausea, vomiting, and IBS-D.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RedHill Biopharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts27 people are listed at RedHill Biopharma Ltd. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for RedHill Biopharma Ltd's next move

See what Strategic adds

RedHill Biopharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.